Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 20 | 2020 | 2303 | 1.700 |
Why?
|
| Monocytes | 8 | 2020 | 257 | 1.680 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2021 | 259 | 1.050 |
Why?
|
| Insulin Resistance | 3 | 2020 | 184 | 0.920 |
Why?
|
| Anti-HIV Agents | 7 | 2021 | 420 | 0.910 |
Why?
|
| HIV-1 | 6 | 2020 | 706 | 0.850 |
Why?
|
| Lipoproteins, LDL | 1 | 2020 | 62 | 0.730 |
Why?
|
| Anti-Retroviral Agents | 3 | 2019 | 147 | 0.690 |
Why?
|
| Myeloid Cells | 1 | 2019 | 29 | 0.670 |
Why?
|
| Albuminuria | 2 | 2016 | 76 | 0.650 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2016 | 93 | 0.520 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2020 | 234 | 0.480 |
Why?
|
| Carotid Artery Diseases | 2 | 2020 | 22 | 0.320 |
Why?
|
| Middle Aged | 16 | 2021 | 10129 | 0.320 |
Why?
|
| Receptors, Immunologic | 2 | 2019 | 61 | 0.300 |
Why?
|
| Coronary Vessels | 2 | 2019 | 85 | 0.290 |
Why?
|
| Inflammation | 4 | 2018 | 618 | 0.250 |
Why?
|
| Male | 16 | 2021 | 20025 | 0.230 |
Why?
|
| Humans | 21 | 2021 | 37093 | 0.230 |
Why?
|
| Female | 16 | 2021 | 20969 | 0.220 |
Why?
|
| Cross-Sectional Studies | 7 | 2020 | 2721 | 0.210 |
Why?
|
| Virus Latency | 2 | 2019 | 42 | 0.210 |
Why?
|
| Receptors, CCR2 | 2 | 2018 | 26 | 0.200 |
Why?
|
| Receptors, CCR5 | 2 | 2018 | 61 | 0.200 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2020 | 356 | 0.200 |
Why?
|
| Carotid Stenosis | 1 | 2020 | 13 | 0.190 |
Why?
|
| Antirheumatic Agents | 1 | 2020 | 31 | 0.190 |
Why?
|
| Fasting | 1 | 2020 | 54 | 0.180 |
Why?
|
| Interleukin-8 | 1 | 2020 | 60 | 0.180 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 70 | 0.180 |
Why?
|
| Viral Load | 2 | 2018 | 312 | 0.180 |
Why?
|
| Blood Platelets | 1 | 2020 | 77 | 0.180 |
Why?
|
| AIDS Dementia Complex | 1 | 2021 | 102 | 0.180 |
Why?
|
| Oxidative Phosphorylation | 1 | 2020 | 53 | 0.180 |
Why?
|
| Autoantibodies | 1 | 2021 | 103 | 0.180 |
Why?
|
| Interleukin-6 | 1 | 2020 | 153 | 0.180 |
Why?
|
| Galectins | 1 | 2019 | 28 | 0.170 |
Why?
|
| Erythrocyte Indices | 1 | 2018 | 13 | 0.170 |
Why?
|
| Cytokines | 2 | 2020 | 602 | 0.170 |
Why?
|
| Genetic Markers | 1 | 2019 | 142 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 55 | 0.160 |
Why?
|
| E-Selectin | 1 | 2018 | 21 | 0.160 |
Why?
|
| Blood Glucose | 1 | 2020 | 353 | 0.160 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2016 | 159 | 0.160 |
Why?
|
| Erythrocytes | 1 | 2018 | 111 | 0.160 |
Why?
|
| Imidazoles | 1 | 2018 | 126 | 0.150 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 204 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 169 | 0.150 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2017 | 23 | 0.150 |
Why?
|
| Lymphocyte Activation | 4 | 2020 | 236 | 0.140 |
Why?
|
| Mitochondria | 1 | 2020 | 487 | 0.140 |
Why?
|
| Receptors, IgG | 1 | 2016 | 50 | 0.140 |
Why?
|
| Atrophy | 1 | 2016 | 42 | 0.140 |
Why?
|
| Deoxyguanosine | 1 | 2016 | 35 | 0.140 |
Why?
|
| DNA Methylation | 1 | 2019 | 325 | 0.130 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 357 | 0.130 |
Why?
|
| Chronic Disease | 2 | 2016 | 484 | 0.130 |
Why?
|
| Serum Amyloid P-Component | 1 | 2015 | 20 | 0.130 |
Why?
|
| Brachial Artery | 1 | 2015 | 28 | 0.130 |
Why?
|
| Vasodilation | 1 | 2015 | 65 | 0.130 |
Why?
|
| Fibrosis | 1 | 2016 | 159 | 0.130 |
Why?
|
| Acute-Phase Proteins | 1 | 2014 | 14 | 0.130 |
Why?
|
| Chemokine CCL2 | 1 | 2016 | 85 | 0.130 |
Why?
|
| Cognition | 1 | 2018 | 398 | 0.130 |
Why?
|
| DNA, Mitochondrial | 1 | 2016 | 175 | 0.120 |
Why?
|
| Calcium | 1 | 2016 | 480 | 0.110 |
Why?
|
| Hippocampus | 1 | 2016 | 561 | 0.110 |
Why?
|
| RNA, Viral | 3 | 2020 | 301 | 0.100 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2018 | 221 | 0.100 |
Why?
|
| Retrospective Studies | 1 | 2016 | 2026 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 664 | 0.080 |
Why?
|
| Hawaii | 3 | 2020 | 1929 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 2 | 2018 | 75 | 0.070 |
Why?
|
| Aged | 1 | 2016 | 6741 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 885 | 0.060 |
Why?
|
| Disease Progression | 2 | 2016 | 601 | 0.060 |
Why?
|
| Phenotype | 2 | 2016 | 689 | 0.060 |
Why?
|
| Autoantigens | 1 | 2021 | 81 | 0.050 |
Why?
|
| CD4-CD8 Ratio | 1 | 2020 | 30 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 237 | 0.040 |
Why?
|
| Risk Factors | 2 | 2020 | 3562 | 0.040 |
Why?
|
| Uganda | 1 | 2019 | 22 | 0.040 |
Why?
|
| CpG Islands | 1 | 2019 | 97 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2019 | 79 | 0.040 |
Why?
|
| Virus Activation | 1 | 2019 | 35 | 0.040 |
Why?
|
| Sulfoxides | 1 | 2018 | 16 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2018 | 77 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 186 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 120 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2018 | 56 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2019 | 110 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 112 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 610 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2019 | 142 | 0.040 |
Why?
|
| Aorta | 1 | 2018 | 167 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 259 | 0.040 |
Why?
|
| Adult | 3 | 2018 | 11712 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2018 | 134 | 0.040 |
Why?
|
| Virus Replication | 1 | 2019 | 278 | 0.040 |
Why?
|
| Logistic Models | 1 | 2019 | 923 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2016 | 57 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1130 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 578 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 661 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2016 | 189 | 0.030 |
Why?
|
| Cell Separation | 1 | 2016 | 93 | 0.030 |
Why?
|
| Calcinosis | 1 | 2016 | 59 | 0.030 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2016 | 57 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2016 | 128 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2018 | 308 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 1378 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 1354 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 767 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 214 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2016 | 399 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 1518 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2016 | 304 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 623 | 0.030 |
Why?
|
| Prognosis | 1 | 2016 | 739 | 0.030 |
Why?
|
| DNA Damage | 1 | 2016 | 352 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 461 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 481 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 2231 | 0.030 |
Why?
|
| Aging | 1 | 2016 | 664 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 1908 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2016 | 938 | 0.020 |
Why?
|
| Animals | 1 | 2016 | 15081 | 0.010 |
Why?
|